[go: up one dir, main page]

DE69108014D1 - Verfahren zur herstellung von nucleosiden und ihre analogen. - Google Patents

Verfahren zur herstellung von nucleosiden und ihre analogen.

Info

Publication number
DE69108014D1
DE69108014D1 DE69108014T DE69108014T DE69108014D1 DE 69108014 D1 DE69108014 D1 DE 69108014D1 DE 69108014 T DE69108014 T DE 69108014T DE 69108014 T DE69108014 T DE 69108014T DE 69108014 D1 DE69108014 D1 DE 69108014D1
Authority
DE
Germany
Prior art keywords
nucleoside
analogs
cyclonucleoside
cytarabine
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69108014T
Other languages
English (en)
Other versions
DE69108014T2 (de
Inventor
Khashayar Karimian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apotex Pharmachem Inc
Original Assignee
Acic Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2012093 external-priority patent/CA2012093C/en
Priority claimed from CA 2012094 external-priority patent/CA2012094C/en
Application filed by Acic Canada Inc filed Critical Acic Canada Inc
Publication of DE69108014D1 publication Critical patent/DE69108014D1/de
Application granted granted Critical
Publication of DE69108014T2 publication Critical patent/DE69108014T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69108014T 1990-03-13 1991-03-13 Verfahren zur herstellung von nucleosiden und ihre analogen. Expired - Fee Related DE69108014T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2012093 CA2012093C (en) 1990-03-13 1990-03-13 Process for producing 2,2'-cyclocytidine and analogues thereof
CA 2012094 CA2012094C (en) 1990-03-13 1990-03-13 Process for producing cytarabine and analogues thereof
PCT/CA1991/000077 WO1991013900A1 (en) 1990-03-13 1991-03-13 Process for producing 2,2'-o-cyclonucleosides, nucleosides, and analogs thereof

Publications (2)

Publication Number Publication Date
DE69108014D1 true DE69108014D1 (de) 1995-04-13
DE69108014T2 DE69108014T2 (de) 1995-07-06

Family

ID=25674007

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69108014T Expired - Fee Related DE69108014T2 (de) 1990-03-13 1991-03-13 Verfahren zur herstellung von nucleosiden und ihre analogen.

Country Status (8)

Country Link
US (1) US5610292A (de)
EP (1) EP0521923B1 (de)
AT (1) ATE119541T1 (de)
AU (1) AU7473791A (de)
BR (1) BR9106158A (de)
DE (1) DE69108014T2 (de)
HU (1) HUT61566A (de)
WO (1) WO1991013900A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995035102A1 (en) * 1994-06-22 1995-12-28 Nexstar Pharmaceuticals, Inc. Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement
IT1277425B1 (it) 1995-08-03 1997-11-10 Pro Bio Sint Srl Metodo per la preparazione della 1-b-d-arabinofuranosilcitosina
US6737236B1 (en) 1997-01-08 2004-05-18 Proligo, Llc Bioconjugation of macromolecules
US7427678B2 (en) 1998-01-08 2008-09-23 Sigma-Aldrich Co. Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
KR100448211B1 (ko) * 2000-04-13 2004-09-13 미쯔이카가쿠 가부시기가이샤 시티딘유도체의 제조방법
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2003062452A2 (en) 2002-01-23 2003-07-31 Proligo, Llc Methods for the integrated synthesis and purification of oligonucleotides
AU2002361255A1 (en) 2002-12-31 2004-07-22 Proligo Llc Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support
EP1668023A1 (de) * 2003-09-12 2006-06-14 Max-Delbrück-Centrum Für Molekulare Medizin B-l-nucleoside und ihre verwendung als pharmazeutische mittel zur behandlung viraler erkrankungen
CN1300326C (zh) * 2004-12-22 2007-02-14 华南理工大学 酶催化制备阿糖胞苷酯的方法
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
US8404830B2 (en) 2007-07-17 2013-03-26 Somalogic, Inc. Method for generating aptamers with improved off-rates
CN102014919B (zh) 2008-03-03 2015-02-25 托斯克公司 减少毒性的甲氨蝶呤佐剂及其使用方法
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
ES2610159T3 (es) 2010-04-12 2017-04-26 Somalogic, Inc. Aptámeros para ß-NGF y su uso en el tratamiento de enfermedades y trastornos mediados por ß-NGF
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CA2928207C (en) 2013-11-21 2020-09-15 Somalogic, Inc. Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652554A (en) * 1982-02-22 1987-03-24 St. Jude Children's Research Hospital Nitro-substituted 1-β-D-arabinofuranosylcytosines
WO1991013901A1 (en) * 1990-03-13 1991-09-19 Acic (Canada) Inc. 3'-o-tosylcytidine and cytosine compounds, and process for production thereof

Also Published As

Publication number Publication date
WO1991013900A1 (en) 1991-09-19
EP0521923A1 (de) 1993-01-13
EP0521923B1 (de) 1995-03-08
AU7473791A (en) 1991-10-10
ATE119541T1 (de) 1995-03-15
HUT61566A (en) 1993-01-28
US5610292A (en) 1997-03-11
BR9106158A (pt) 1993-03-16
DE69108014T2 (de) 1995-07-06
HU9202906D0 (en) 1992-11-30

Similar Documents

Publication Publication Date Title
DE69108014D1 (de) Verfahren zur herstellung von nucleosiden und ihre analogen.
ATE237613T1 (de) Verfahren für die herstellung von antiviralen substituierten 1, 3-oxathiolanen
ATE194601T1 (de) Verfahren zur herstellung von pyrimidinverbindungen
AT380252B (de) Verfahren zur herstellung von neuen guanin- und 2,6-diaminopurinderivaten und ihren salzen
ATE22889T1 (de) 8-chlor-1,5-benzothiazepinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
EP0236935A3 (de) Carbozyklische Purinnukleoside, ihre Herstellung und Anwendung
ATE74603T1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
ATE158798T1 (de) Verfahren zur herstellung von optisch aktiven zyklobutannukleosiden
DE3762615D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
ATE198479T1 (de) Verfahren zur herstellung von purinderivaten
ATE48278T1 (de) Verfahren zur herstellung von 2'desoxyadenosinverbindungen.
ATE93521T1 (de) Verfahren zur herstellung von substituierten indolinonderivaten.
SE7910376L (sv) Kinazolinonderivat
DE3788921D1 (de) Verfahren zur Herstellung von 5-Methyltetrazol.
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
DE69404953D1 (de) Verfahren zur Herstellung von AZT und Derivaten davon
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
DE69129971D1 (de) Verfahren zur herstellung von 9-beta-d-arabinofuranosyl-2-fluoroadenin 5'-phosphaten
DE3678487D1 (de) Verfahren zur herstellung von 6-amino-3-hydrazino-pyridazinderivaten.
DE3777464D1 (de) Fluorine enthaltende vitamin-d3-derivate und verfahren zu ihrer herstellung.
DE59803194D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
CA2012093A1 (en) Process for producing 2,2'-cyclocytidine and analogues thereof
CA2012094A1 (en) Process for producing cytarabine and analogues thereof
ATE156131T1 (de) Verbessertes verfahren zur herstellung von 2- amino(2,3,5-tri-o-benzyl-beta-d- arabinofuranosyl)adenin
TH9308A (th) พิริมิดีนคลีโอไซด์ที่ใช้ต้านไวรัส

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee